Navegar

Colección

Datos Estadísticas

Lista de

angiogenesis inhibitor
7
"Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys" (2018) Abiuso, A.M.B.;Varela, M.L.;Haro Durand, L. (...)Mondillo, C. European Journal of Cancer. 91:125-135
"Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome" (2014) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Journal of Steroid Biochemistry and Molecular Biology. 144(PART B):392-401
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"A natural antiviral and immunomodulatory compound with antiangiogenic properties" (2012) Bueno, C.A.; Lombardi, M.G.; Sales, M.E.; Alché, L.E. Microvascular Research. 84(3):235-241
"Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1)" (2012) Recouvreux, M.V.;Camilletti, M.A.;Rifkin, D.B. (...)Díaz-Torga, G. Endocrinology. 153(8):3861-3871